|
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z # |
Alpha Aminoadipic Semialdehyde (CSF)
Test Code10377
CPT Codes
82542<br>Restricted Client Code
Preferred Specimen
1 mL frozen CSF collected in a sterile screw-cap vial
Minimum Volume
0.5 mL
Instructions
Collect entire sample into a single sterile tube.
Storage Instructions: Freeze as soon as possible after collection
Storage Instructions: Freeze as soon as possible after collection
Transport Temperature
Frozen
Specimen Stability
Room temperature: Not stable
Refrigerated: 24 hours
Frozen -20° C: 72 hours
Frozen -80° C: Indefinitely
Refrigerated: 24 hours
Frozen -20° C: 72 hours
Frozen -80° C: Indefinitely
Reject Criteria (Eg, hemolysis? Lipemia? Thaw/Other?)
Received thawed • Bloody CSF
Methodology
LC/MS/MS
FDA Status
This test was developed and its performance characteristics determined by Medical Neurogenetics, LCC. It has not been cleared or approved by the U.S. FDA.
Setup Schedule
Set up: Varies; Report available: 10-14 days
Reference Range
<0.1 umol/L
Clinical Significance
CSF Alpha aminoadipic semialdehyde is useful for diagnosing pyridoxine-dependent seizures (PDS) and folinic acid-responsive seizures (FRS). This testing may also be used for assessment of Variants of Uncertain Significance (VUS) identified during genetic testing (e.g. Next Generation Sequencing or Capillary Sequencing Testing). CLINICAL Pyridoxine dependent seizures is a genetic disorder characterized by seizures in neonates or infants up to 3 years of age, which in general, respond to a pharmacologic dose of pyridoxine (vitamin B6). Alpha-aminoadipic semialdehyde dehydrogenase (antiquin) deficiency is the underlying defect. Piperideine-6-Carboxylate (P6C) is the cyclic isomer of alpha-aminoadipic semialdehyde (AASA) and the equilibrium between P6C and Alpha aminoadipic semialdehyde is pH dependent. Folinic responsive seizures and PDS are allelic, and caused by mutations in the ALDH7A1 gene. Biochemical testing should be done prior to gene sequencing, and can be done regardless of pyridoxine therapy.